Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by threefiftynineon Jul 10, 2020 10:37am

109 Views

Post# 31251160

------NO DISPUTE HERE---

As to the character of Mr Goren as a person ---Obviously as nice as it comes in life---But I don't invest in a company because the CEO is a nice guy----So lets see if this nice guy can actually buy shares in vaxil-or even better -PRODUCE THE GOODS IN THE LAB---Now that's what im talking about------Thus far--zero on all counts----5 trading days to go

<< Previous

Bullboard Posts

Next >>

Fortuna reports record earnings for Q3 2024